Aspac Iii Acquisition CORP

A SPAC III Acquisition Corp. received a notice from Nasdaq indicating non-compliance with minimum stockholders' equity requirements, triggering a 45-day period to submit a compliance plan.

ASPAC III Acquisition Corp. completed a share exchange with its Sponsor, resulting in the Sponsor holding approximately 76.4% of the Company's Class A ordinary shares.

ASPAC III Acquisition Corp. shareholders approved an amendment to extend the deadline for completing a business combination by 12 months to November 12, 2026.

ASPAC III Acquisition Corp. has entered into a definitive merger agreement to combine with Bioserica International Limited, a bio-based antimicrobial materials company, in a transaction valued at $200 million to be paid entirely in stock, with potential for additional earnout shares.

A SPAC III Acquisition Corp. has entered into an agreement with Bioserica International Limited, a bio-based antimicrobial materials company, for a potential business combination.

A SPAC III Acquisition Corp. will allow separate trading of its Class A ordinary shares and rights starting on or about January 3, 2025.

ASPAC III Acquisition Corp. reports continued operational inactivity and significant challenges, including a potential Nasdaq delisting and substantial doubt regarding its going concern status, as it seeks a business combination.

A SPAC III Acquisition Corp. reports a net loss of $113,988 for the first quarter of 2026 as it continues to pursue a business combination with Bioserica.

ASPAC III Acquisition Corp. reported a net income increase but faces substantial doubt about its going concern status following significant share redemptions and a reduced trust account balance.

A SPAC III Acquisition Corp. has entered into a definitive merger agreement with Bioserica International Limited, a bio-based antimicrobial materials company, valued at $217.86 million.

A SPAC III Acquisition Corp. reports a net income of $413,202 for the quarter ended March 31, 2025, driven by interest income from its trust account.

A SPAC III Acquisition Corp. reported a net loss for the three and nine months ended September 30, 2024, as it continues to seek a business combination target.

A SPAC III Acquisition Corp. reports its 2025 annual results, detailing a terminated deal, a new merger agreement with Bioserica, significant shareholder redemptions, and an extended business combination deadline to November 2026.

A SPAC III Acquisition Corp.'s 10-K filing details its focus on ESG and material technology sectors, potential mergers with HD Group and Bioserica, and associated risks, particularly concerning China-based operations.

A SPAC III Acquisition Corp. has announced a definitive merger agreement with Bioserica International Limited, a bio-based antimicrobial materials company, in a stock-for-stock transaction valued at $200 million.

A SPAC III Acquisition Corp. has entered into an agreement with Bioserica International Limited, a bio-based antimicrobial materials company, for a merger transaction valued at $200 million.

A SPAC III Acquisition Corp. has entered into an agreement with HDEducation Group Limited, a comprehensive service platform for students pursuing university education globally, for a merger transaction valued at $300 million.

A SPAC III Acquisition Corp. has announced it is exploring potential business combinations with two companies, one in education technology and the other in consumer material technology.

ASPAC III (Holdings) Corp., a significant shareholder in ASPAC III Acquisition Corp., has reported changes in its beneficial ownership, including the acquisition of Class A ordinary shares and the forfeiture of Class B ordinary shares.

Claudius Tsang, CEO and CFO of ASPAC III Acquisition Corp., reports the acquisition of 5,000 Class A ordinary shares and the forfeiture of 81,250 Class B ordinary shares.

A SPAC III Acquisition Corp. seeks shareholder approval to extend its business combination deadline to November 2026, with new terms impacting trust account contributions.

A SPAC III Acquisition Corp. is seeking to raise $55 million through an IPO to pursue a business combination in the ESG and material technology sectors.

A SPAC III Acquisition Corp. files an amendment to its S-1 registration statement for a $55 million initial public offering targeting the ESG and material technology sectors.

A SPAC III Acquisition Corp., a newly formed blank check company, has filed an S-1 registration statement for a $55 million initial public offering, with plans to target businesses in the Environmental, Sustainability and Governance (ESG) and material technology sectors.

Mizuho Financial Group, Inc. has filed an amendment to its Schedule 13G, indicating it no longer holds a beneficial ownership stake in A SPAC III Acquisition Corp.

Bank of Montreal and its affiliates have filed an amended Schedule 13G, reporting zero beneficial ownership of ASPAC III Acquisition Corp.'s Class A ordinary shares.

W. R. Berkley Corporation and Berkley Insurance Company report zero beneficial ownership in A SPAC III Acquisition Corp. Class A ordinary shares.

ATW SPAC Management LLC and its principals report zero beneficial ownership in A SPAC III Acquisition Corp. Class A ordinary shares.

Boothbay Fund Management LLC and affiliates report 0% beneficial ownership in ASPAC III Acquisition Corp. as of September 30, 2025, marking a complete divestment.

ATW SPAC Management LLC, Kerry Propper, and Antonio Ruiz-Gimenez have reported significant beneficial ownership in A SPAC III Acquisition Corp., with Propper and Ruiz-Gimenez each holding 7.5%.